Abound Wealth Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.6K Sell
109
-1
-0.9% -$423 0.01% 259
2026
Q1
$52.1K Hold
110
0.01% 240
2025
Q4
$51.4K Sell
110
-9
-8% -$4.18K 0.01% 224
2025
Q3
$50.7K Buy
119
+26
+28% +$10.1K 0.01% 211
2025
Q2
$35.5K Hold
93
0.01% 251
2025
Q1
$32K Buy
93
+1
+1% +$322 0.01% 244
2024
Q4
$27.7K Hold
92
0.01% 238
2024
Q3
$37.5K Hold
92
0.01% 216
2024
Q2
$29.6K Sell
92
-3
-3% -$975 0.01% 210
2024
Q1
$31.6K Hold
95
0.01% 193
2023
Q4
$25.6K Sell
95
-33
-26% -$8.16K 0.01% 218
2023
Q3
$31.4K Buy
128
+3
+2% +$821 0.01% 172
2023
Q2
$38.1K Buy
125
+3
+2% +$834 0.02% 156
2023
Q1
$32.3K Hold
122
0.01% 162
2022
Q4
$29.3K Sell
122
-102
-46% -$22.8K 0.01% 158
2022
Q3
$41.2K Buy
+224
New +$44.6K 0.02% 129

Other funds holding HCA

Abound Wealth Management's HCA Position: Q2 2026 in Review

Abound Wealth Management reduced its HCA Healthcare (HCA) stake by 0.91% in Q2 2026, selling an estimated $423 and leaving 109 shares worth $42.6K. The position accounts for 0.01% of the portfolio, ranked #259.

Abound Wealth Management first reported a position in HCA in Q3 2022 and has held it in 16 quarters since. The position peaked at $52.1K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Abound Wealth Management held 109 shares of HCA Healthcare worth $42.6K as of Q2 2026.
  • Abound Wealth Management sold 1 HCA Healthcare share in Q2 2026, an estimated $423.
  • HCA Healthcare made up 0.01% of Abound Wealth Management's portfolio in Q2 2026, its #259 holding.
  • Abound Wealth Management first reported a position in HCA Healthcare in Q3 2022 and has held it in 16 quarters since.
  • Abound Wealth Management's HCA Healthcare position peaked at $52.1K in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.